Spine Aclarion Announces Commercial Agreement with Spine Institute of Louisiana byTim AllenApril 29, 2025
Financial Spine Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis byTim AllenApril 21, 2025
Financial Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives byTim AllenMarch 31, 2025
Regulatory Spine Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body byTim AllenFebruary 11, 2025
Financial Spine Top Stories Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded byJosh SandbergFebruary 4, 2025
Spine Top Stories Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference byJosh SandbergJanuary 31, 2025
Spine Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash byJosh SandbergNovember 21, 2024
Spine PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology byJosh SandbergSeptember 13, 2024
